Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

106 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Biofeedback for treatment of irritable bowel syndrome.
Goldenberg JZ, Brignall M, Hamilton M, Beardsley J, Batson RD, Hawrelak J, Lichtenstein B, Johnston BC. Goldenberg JZ, et al. Among authors: lichtenstein b. Cochrane Database Syst Rev. 2019 Nov 12;2019(11):CD012530. doi: 10.1002/14651858.CD012530.pub2. Cochrane Database Syst Rev. 2019. PMID: 31713856 Free PMC article.
Nutrition and HIV.
Lichtenstein BS. Lichtenstein BS. STEP Perspect. 1995 Spring;7(1):2-5. STEP Perspect. 1995. PMID: 11362399
Psychoneuroimmunology and HIV.
Lichtenstein B. Lichtenstein B. STEP Perspect. 1995 Summer;7(2):6-9. STEP Perspect. 1995. PMID: 11362722
Improving HAART naturally.
Lichtenstein BS. Lichtenstein BS. STEP Perspect. 1999 Summer;99(2):10-2. STEP Perspect. 1999. PMID: 11366744
Concentration-Dependent Inhibition of Mesophilic PETases on Poly(ethylene terephthalate) Can Be Eliminated by Enzyme Engineering.
Avilan L, Lichtenstein BR, König G, Zahn M, Allen MD, Oliveira L, Clark M, Bemmer V, Graham R, Austin HP, Dominick G, Johnson CW, Beckham GT, McGeehan JE, Pickford AR. Avilan L, et al. Among authors: lichtenstein br. ChemSusChem. 2023 Apr 21;16(8):e202202277. doi: 10.1002/cssc.202202277. Epub 2023 Mar 23. ChemSusChem. 2023. PMID: 36811288
Triglyceride Lowering with Pemafibrate to Reduce Cardiovascular Risk.
Das Pradhan A, Glynn RJ, Fruchart JC, MacFadyen JG, Zaharris ES, Everett BM, Campbell SE, Oshima R, Amarenco P, Blom DJ, Brinton EA, Eckel RH, Elam MB, Felicio JS, Ginsberg HN, Goudev A, Ishibashi S, Joseph J, Kodama T, Koenig W, Leiter LA, Lorenzatti AJ, Mankovsky B, Marx N, Nordestgaard BG, Páll D, Ray KK, Santos RD, Soran H, Susekov A, Tendera M, Yokote K, Paynter NP, Buring JE, Libby P, Ridker PM; PROMINENT Investigators. Das Pradhan A, et al. N Engl J Med. 2022 Nov 24;387(21):1923-1934. doi: 10.1056/NEJMoa2210645. Epub 2022 Nov 5. N Engl J Med. 2022. PMID: 36342113 Clinical Trial.
106 results